Teresa G Hayes
Overview
Explore the profile of Teresa G Hayes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
553
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Arney J, Helm A, Braun U, Chen G, Hayes T
Fed Pract
. 2019 Feb;
35(Suppl 1):S53-S57.
PMID: 30766390
Reflexive testing, standardization of the mutation test ordering procedure and results reporting, and elimination of the preauthorization requirements could facilitate the utilization of targeted therapies.
2.
Maldonado M, Molfese D, Viswanath H, Curtis K, Jones A, Hayes T, et al.
J Cachexia Sarcopenia Muscle
. 2018 Mar;
9(3):497-504.
PMID: 29575771
Background: Little is known about the brain mechanisms underlying cancer-associated weight loss (C-WL) in humans despite this condition negatively affecting their quality of life and survival. We tested the hypothesis...
3.
Arney J, Helm A, Crook T, Braun U, Chen G, Hayes T
Lung Cancer
. 2018 Feb;
116:25-29.
PMID: 29413047
Current national guidelines recommend genomic testing on all stage 4 non-small cell lung cancers (NSCLC) of adenocarcinoma histology. Mutations are most often found among young, Asian, females without a history...
4.
Lerner L, Hayes T, Tao N, Krieger B, Feng B, Wu Z, et al.
J Cachexia Sarcopenia Muscle
. 2015 Dec;
6(4):317-24.
PMID: 26672741
Background: Cancer-related weight loss is associated with increased inflammation and decreased survival. The novel inflammatory mediator growth differentiation factor (GDF)15 is associated with poor prognosis in cancer but its role...
5.
Girnius S, Lee S, Kambhampati S, Rose M, Mohiuddin A, Houranieh A, et al.
Br J Haematol
. 2015 Jan;
169(1):36-43.
PMID: 25572917
Once-weekly administration of bortezomib has reduced bortezomib-induced peripheral neuropathy without affecting response rates, but this has only been demonstrated prospectively in three- and four- drug combinations. We report a phase...
6.
Munker R, Shi R, Lin D, Guo S, Hayes T
Clin Lymphoma Myeloma Leuk
. 2013 Dec;
14(2):102-6.
PMID: 24373789
Background: The prognosis of multiple myeloma (MM) has improved in recent years. Therefore, second malignant neoplasms (SMNs) may become an issue for longer term survivors with MM. An increased incidence...
7.
Engineer D, Burney B, Hayes T, Garcia J
Transl Oncol
. 2013 Oct;
6(5):539-45.
PMID: 24151534
Background: Advanced colon cancer is associated with weight loss and decreased survival. Studies suggest that angiotensin and β-adrenergic blockade decrease colon cancer progression and ameliorate weight loss. This study aims...
8.
Sonpavde G, Wang M, Peterson L, Wang H, Joe T, Mims M, et al.
Invest New Drugs
. 2013 Apr;
32(2):235-242.
PMID: 23609828
Background: Given the immunogenicity of NY-ESO-1 peptides in prostate cancer, a phase I clinical trial was designed to evaluate HLA class-I and class-II restricted NY-ESO-1 peptides in metastatic castration-resistant prostate...
9.
Mediwala S, Sun H, Szafran A, Hartig S, Sonpavde G, Hayes T, et al.
Prostate
. 2012 Jul;
73(3):267-77.
PMID: 22821817
Background: The androgen receptor (AR) AR-V7 splice isoform is a constitutively active outlaw transcription factor. Transition of prostate cancer (PC) to the castration-resistant phenotype correlates with AR-V7 accumulation, suggesting that...
10.
Utech A, Tadros E, Hayes T, Garcia J
J Cachexia Sarcopenia Muscle
. 2012 Jun;
3(4):245-51.
PMID: 22648739
Background: Cancer can lead to weight loss, anorexia, and poor nutritional status, which are associated with decreased survival in cancer patients. Methods: Male cancer patients (n = 136) were followed...